Association of Nicotine Metabolite Ratio and CYP2A6 Genotype With Smoking Cessation Treatment in African-American Light Smokers

Stability of the Nicotine Metabolite Ratio in ad Libitum and Reducing Smokers

(2008) M. E. Mooney et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Toward Personalized Therapy for Smoking Cessation: A Randomized Placebo-controlled Trial of Bupropion

(2008) F Patterson et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Novel and established CYP2A6 alleles impair in vivo nicotine metabolism in a population of Black African descent

(2008) Jill C. Mwenifumbo et al.   HUMAN MUTATION

Assessing dimensions of nicotine dependence: An evaluation of the Nicotine Dependence Syndrome Scale (NDSS) and the Wisconsin Inventory of Smoking Dependence Motives (WISDM)

(2008) Megan Piper et al.   NICOTINE & TOBACCO RESEARCH

A novel CYP2A6 allele, CYP2A6*23, impairs enzyme function in vitro and in vivo and decreases smoking in a population of Black-African descent

(2008) Man Ki Ho et al.   Pharmacogenetics and Genomics

Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: A validation study

(2008) Robert A. Schnoll et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR